Format
Sort by
Items per page

Send to

Choose Destination

Best matches for NPY schizophrenia:

Search results

Items: 1 to 20 of 76

1.

Propionate Protects Haloperidol-Induced Neurite Lesions Mediated by Neuropeptide Y.

Hu M, Zheng P, Xie Y, Boz Z, Yu Y, Tang R, Jones A, Zheng K, Huang XF.

Front Neurosci. 2018 Oct 15;12:743. doi: 10.3389/fnins.2018.00743. eCollection 2018.

2.

Laminar Distribution of Neurochemically-Identified Interneurons and Cellular Co-expression of Molecular Markers in Epileptic Human Cortex.

Zhu Q, Ke W, He Q, Wang X, Zheng R, Li T, Luan G, Long YS, Liao WP, Shu Y.

Neurosci Bull. 2018 Dec;34(6):992-1006. doi: 10.1007/s12264-018-0275-x. Epub 2018 Aug 31.

3.

Ulk4 regulates GABAergic signaling and anxiety-related behavior.

Liu M, Fitzgibbon M, Wang Y, Reilly J, Qian X, O'Brien T, Clapcote S, Shen S, Roche M.

Transl Psychiatry. 2018 Feb 2;8(1):43. doi: 10.1038/s41398-017-0091-5.

4.

Effect of clozapine dose and concentration on fasting concentration of appetite regulating peptides.

Margulska A, Kozłowska E, Wysokiński A.

Psychiatry Res. 2018 Feb;260:473-477. doi: 10.1016/j.psychres.2017.12.018. Epub 2017 Dec 10.

PMID:
29275180
5.

A prenatal interruption of DISC1 function in the brain exhibits a lasting impact on adult behaviors, brain metabolism, and interneuron development.

Deng D, Jian C, Lei L, Zhou Y, McSweeney C, Dong F, Shen Y, Zou D, Wang Y, Wu Y, Zhang L, Mao Y.

Oncotarget. 2017 Sep 28;8(49):84798-84817. doi: 10.18632/oncotarget.21381. eCollection 2017 Oct 17.

6.

The central mechanism of risperidone-induced hyperprolactinemia.

Sun WW, Li LY, Huang XF, Shi YC, Yang HQ, Song ZY, Lin S.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:134-139. doi: 10.1016/j.pnpbp.2017.03.009. Epub 2017 Mar 20.

PMID:
28336493
7.

Neuropeptide Y neuronal network dysfunction in the frontal lobe of a genetic mouse model of schizophrenia.

Morosawa S, Iritani S, Fujishiro H, Sekiguchi H, Torii Y, Habuchi C, Kuroda K, Kaibuchi K, Ozaki N.

Neuropeptides. 2017 Apr;62:27-35. doi: 10.1016/j.npep.2016.12.010. Epub 2017 Jan 5.

PMID:
28073591
8.

Association study of arcuate nucleus neuropeptide Y neuron receptor gene variation and serum NPY levels in clozapine treated patients with schizophrenia.

Klemettilä JP, Kampman O, Solismaa A, Lyytikäinen LP, Seppälä N, Viikki M, Hämäläinen M, Moilanen E, Mononen N, Lehtimäki T, Leinonen E.

Eur Psychiatry. 2017 Feb;40:13-19. doi: 10.1016/j.eurpsy.2016.07.004. Epub 2016 Nov 10.

PMID:
27837667
9.

Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation.

Wagner L, Kaestner F, Wolf R, Stiller H, Heiser U, Manhart S, Hoffmann T, Rahfeld JU, Demuth HU, Rothermundt M, von Hörsten S.

Neuropeptides. 2016 Jun;57:21-34. doi: 10.1016/j.npep.2016.02.007. Epub 2016 Feb 27.

PMID:
26988064
10.

Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.

Lian J, Huang XF, Pai N, Deng C.

Pharmacol Res. 2016 Apr;106:51-63. doi: 10.1016/j.phrs.2016.02.011. Epub 2016 Feb 15. Review.

PMID:
26892184
11.

Fasting serum levels of neuropeptide y in patients with schizophrenia on clozapine monotherapy.

Wysokiński A.

Clin Neuropharmacol. 2015 Jan-Feb;38(1):18-22. doi: 10.1097/WNF.0000000000000062.

PMID:
25580919
12.

Social feeding in Caenorhabditis elegans is modulated by antipsychotic drugs and calmodulin and may serve as a protophenotype for asociality.

Dwyer DS, Awatramani P, Thakur R, Seeni R, Aamodt EJ.

Neuropharmacology. 2015 May;92:56-62. doi: 10.1016/j.neuropharm.2014.12.027. Epub 2015 Jan 7.

PMID:
25576370
13.

Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats.

Kursungoz C, Ak M, Yanik T.

Brain Res. 2015 Jan 30;1596:146-55. doi: 10.1016/j.brainres.2014.10.070. Epub 2014 Nov 20.

PMID:
25449893
14.

Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment.

Lian J, Huang XF, Pai N, Deng C.

PLoS One. 2014 Aug 1;9(8):e104160. doi: 10.1371/journal.pone.0104160. eCollection 2014.

15.

Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.

Lian J, Huang XF, Pai N, Deng C.

Psychoneuroendocrinology. 2014 Oct;48:77-86. doi: 10.1016/j.psyneuen.2014.06.010. Epub 2014 Jun 18.

PMID:
24992721
16.

Neuropeptide Y, social function and long-term outcome in schizophrenia.

Stålberg G, Ekselius L, Lindström LH, Larhammar D, Bodén R.

Schizophr Res. 2014 Jul;156(2-3):223-7. doi: 10.1016/j.schres.2014.04.006. Epub 2014 May 3.

PMID:
24799298
17.

Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia.

Martin DA, Marona-Lewicka D, Nichols DE, Nichols CD.

Neuropharmacology. 2014 Aug;83:1-8. doi: 10.1016/j.neuropharm.2014.03.013. Epub 2014 Apr 3.

18.

Humans and great apes share increased neocortical neuropeptide Y innervation compared to other haplorhine primates.

Raghanti MA, Edler MK, Meindl RS, Sudduth J, Bohush T, Erwin JM, Stimpson CD, Hof PR, Sherwood CC.

Front Hum Neurosci. 2014 Feb 28;8:101. doi: 10.3389/fnhum.2014.00101. eCollection 2014.

19.

Modulation of behavioral networks by selective interneuronal inactivation.

Schmidt MJ, Horvath S, Ebert P, Norris JL, Seeley EH, Brown J, Gellert L, Everheart M, Garbett KA, Grice TW, Caprioli RM, Mirnics K.

Mol Psychiatry. 2014 May;19(5):580-7. doi: 10.1038/mp.2013.167. Epub 2013 Dec 10.

20.

Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia.

Stadlbauer U, Langhans W, Meyer U.

Neuropsychopharmacology. 2013 Nov;38(12):2446-55. doi: 10.1038/npp.2013.146. Epub 2013 Jun 10.

Supplemental Content

Loading ...
Support Center